Heteroaroyl amides as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
US-2024174679-A1 · May 30, 2024 · US
This page is not indexed by search engines while we improve data quality.
Ellis J Michael patents
Ellis J Michael holds 4 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 4 |
| Recent patents | 1 |
| First publication | Oct 15, 2019 |
| Latest publication | May 30, 2024 |
Filing trend
Year-over-year patent counts for this assignee.
Recent patents
Latest publications where this party is an assignee.
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
US-11161854-B2 · Nov 2, 2021 · US
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
US-2021188863-A1 · Jun 24, 2021 · US
Tricyclic compounds as inhibitors of mutant IDH enzymes
US-10442819-B2 · Oct 15, 2019 · US
Notable patents
Representative or frequently cited publications from precomputed assignee stats.
Heteroaroyl amides as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
US-2024174679-A1 · May 30, 2024 · US
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof
US-11161854-B2 · Nov 2, 2021 · US
Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as lrrk2 inhibitors, pharmaceutical compositions, and uses thereof
US-2021188863-A1 · Jun 24, 2021 · US
Tricyclic compounds as inhibitors of mutant IDH enzymes
US-10442819-B2 · Oct 15, 2019 · US
Technology areas
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Chemistry & Metallurgy | 4 |
| Human Necessities | 2 |